ferrum hausmann 100 milligram tablets chewable
vifor france - ferric hydroxide polymaltose complex - tablets chewable - 100 milligram - iron trivalent, oral preparations
ferrifol
cts chemical industries ltd, israel - ferrous as iron iii hydroxide polymaltose compl.; folic acid - tablets - folic acid 0.4 mg; ferrous as iron iii hydroxide polymaltose compl. 100 mg - ferrous amino acid complex - ferrous amino acid complex - prevention and treatment of anemia caused by iron and folic acid deficiency including anemia of pregnancy and lactation.
eurofer®-iron syrup
eurodrug laboratories (m) sdn. bhd. - iron(iii) hydroxide polymaltose complex -
hemafer 100 mg chewable tabl.
uni-pharma kleon tsetis pharmaceutical laboratories s.a. - iron (iii) hydroxide polymaltose complex 357 mg - eq. iron 100 mg - chewable tablet - 100 mg - iron (iii) hydroxide polymaltose complex 357 mg - ferric oxide polymaltose complexes
orofer chewable tabs tablet
emcure pharmaceuticals ltd t 184, midc, bhosari, pune, maharashtra 411026, - iron iii hydroxide polymaltose complex + folic - tablet - iron (iii) hydroxide polymaltose complex(as - drugs for functional gastrointestinal disorders:
ferrum hausmann syrup 50 mg/5ml oral drops solution
vifor france - ferric hydroxide polymaltose complex - oral drops solution - 50 mg/5ml - iron trivalent, oral preparations
monofer iron (as ferric derisomaltose) 1000 mg/10 ml solution for injection vial
a menarini australia pty ltd - ferric derisomaltose, quantity: 4170 mg (equivalent: iron, qty mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - monofer is indicated for the treatment of iron deficiency in adults, under the following conditions:- when oral iron preparations are ineffective or cannot be used - where there is a clinical need to deliver iron rapidly the diagnosis must be based on laboratory tests.
monofer iron (as ferric derisomaltose) 500 mg/5 ml solution for injection vial
a menarini australia pty ltd - ferric derisomaltose, quantity: 2085 mg (equivalent: iron, qty mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - monofer is indicated for the treatment of iron deficiency in adults, under the following conditions:- when oral iron preparations are ineffective or cannot be used - where there is a clinical need to deliver iron rapidly the diagnosis must be based on laboratory tests.
monofer iron (as ferric derisomaltose) 200 mg/2 ml solution for injection vial
a menarini australia pty ltd - ferric derisomaltose, quantity: 834 mg (equivalent: iron, qty mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - monofer is indicated for the treatment of iron deficiency in adults, under the following conditions:- when oral iron preparations are ineffective or cannot be used - where there is a clinical need to deliver iron rapidly the diagnosis must be based on laboratory tests.
ferinject iron (as ferric carboxymaltose) 1000 mg/20 ml injection vial
seqirus pty ltd - ferric carboxymaltose, quantity: 3.6 g (equivalent: iron, qty 1000 mg) - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - ferinject is indicated for the treatment of iron deficiency in adults and adolescents aged 14 years and older when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used ? there is a clinical need to deliver iron rapidly,the diagnosis of iron deficiency must be based on laboratory tests.,ferinject is indicated for the treatment of iron deficiency anaemia in children aged 1 to 13 years when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used,the diagnosis of iron deficiency anaemia must be based on laboratory tests.